Participant flow18

How many started, completed or left each group, period by period.

1 to 18 of 18

Period	Milestone	Group	Participants
Blinded Study Phase	STARTED	Cilofexor 100 mg	22
Blinded Study Phase	STARTED	Cilofexor 30 mg	20
Blinded Study Phase	STARTED	Placebo	10
Blinded Study Phase	COMPLETED	Cilofexor 100 mg	19
Blinded Study Phase	COMPLETED	Cilofexor 30 mg	19
Blinded Study Phase	COMPLETED	Placebo	10
Blinded Study Phase	NOT COMPLETED	Cilofexor 100 mg	3
Blinded Study Phase	NOT COMPLETED	Cilofexor 30 mg	1
Blinded Study Phase	NOT COMPLETED	Placebo	0
Open Label Extension (OLE) Phase	STARTED	Cilofexor 100 mg	19
Open Label Extension (OLE) Phase	STARTED	Cilofexor 30 mg	18
Open Label Extension (OLE) Phase	STARTED	Placebo	10
Open Label Extension (OLE) Phase	COMPLETED	Cilofexor 100 mg	14
Open Label Extension (OLE) Phase	COMPLETED	Cilofexor 30 mg	11
Open Label Extension (OLE) Phase	COMPLETED	Placebo	8
Open Label Extension (OLE) Phase	NOT COMPLETED	Cilofexor 100 mg	5
Open Label Extension (OLE) Phase	NOT COMPLETED	Cilofexor 30 mg	7
Open Label Extension (OLE) Phase	NOT COMPLETED	Placebo	2

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02943460/flow